Hand Transplant Surgery in India — Composite Tissue Allotransplantation
Hand transplant surgery in India from $40,000. Microsurgical composite tissue allotransplantation after traumatic amputation. Expert reconstructive teams. Book with GAF Healthcare.
Estimated cost: $40,000 – $80,000 · Average stay: 21–30 days
Hand transplantation — the microsurgical attachment of a donor hand from a deceased donor to a recipient who has suffered traumatic amputation — is one of the most complex and psychologically demanding procedures in reconstructive surgery. It is classified as a composite tissue allotransplantation (CTA), involving the transfer of multiple tissue types simultaneously — bone, joint, tendon, nerve, blood vessel, and skin — unlike solid organ transplantation which transfers a single organ type.
The world's first successful hand transplant was performed in Lyon, France in 1998. Since then, over 100 hand transplants have been performed at specialist centres in France, USA, Austria, India, and China. India's premier microsurgery and plastic surgery units at institutes including AIIMS New Delhi, Amrita Institute of Medical Sciences (Kochi), and Christian Medical College Vellore have performed successful hand transplants, with outcomes comparable to the best international series.
Hand transplantation requires lifelong immunosuppression — the same medications used after kidney or liver transplantation — to prevent the immune system from rejecting the transplanted hand. This carries real risks of infection, diabetes, renal toxicity, and malignancy over the long term. Patient selection is therefore critical: hand transplant is most appropriate for patients with bilateral above-wrist amputation (who have the most to gain and face the greatest functional limitation from prosthetics), for younger patients without significant medical comorbidities, and for patients with the psychological resilience and social support to maintain lifelong immunosuppression and intensive hand rehabilitation.
The alternative — a myoelectric prosthetic hand — has improved significantly in recent years and offers functional grip without immunosuppression. For many unilateral amputees, a high-quality prosthetic is the better option. Bilateral amputees, who cannot perform most daily activities with prosthetics alone, are the strongest candidates for hand transplant.
Hand Transplant Candidacy and Assessment
Hand transplant candidacy requires a thorough, multidisciplinary assessment over several months. The evaluation includes: the level, duration, and mechanism of amputation; the condition of the residual limb (stump quality affects both the surgical repair and rehabilitation outcome); the patient's general medical health (no contraindications to immunosuppression); renal function baseline (tacrolimus is nephrotoxic); a comprehensive psychological assessment (body image, motivation, social support, understanding of the implications of lifelong immunosuppression); financial assessment (immunosuppression medications are expensive and lifelong); and blood group and tissue typing (for donor matching).
The hand is classified as a "privileged site" immunologically — skin is highly antigenic, meaning it provokes a strong immune response. The rejection rate in hand transplantation is higher than solid organ transplantation, and most patients experience at least one episode of acute rejection in the first year (typically reversible with increased immunosuppression). Chronic rejection — progressive loss of function from ongoing low-grade immune attack — remains the major long-term challenge and limits the longevity of some hand transplants.
Candidate matching with a donor involves blood group compatibility (and in some centres, HLA matching), body and hand size matching, skin colour matching (for aesthetic acceptability of the transplanted hand), and donor hand laterality (right or left). The waiting time for a matched donor varies from months to years.
Hand Transplant Surgical Procedure
Hand transplant surgery is performed by a team of 6–10 surgeons, anaesthetists, scrub nurses, and perfusionists working simultaneously on the donor procurement team and the recipient preparation team. The operation takes 8–16 hours.
The recipient preparation begins simultaneously with donor hand procurement. The amputation stump is prepared — skin, muscles, tendons, nerves, and blood vessels are identified, dissected, and tagged for anastomosis.
The donor hand is flushed with cold preservation solution (University of Wisconsin solution) and transported in cold ischaemia to the recipient centre. Cold ischaemia time should ideally be under 6 hours to minimise ischaemia-reperfusion injury.
The bone fixation is performed first — the donor radius and ulna are secured to the recipient's cut bone ends using internal fixation plates and screws. This provides skeletal stability for the subsequent soft tissue repairs. The radial and ulnar arteries (and the dominant venae comitantes) are anastomosed microsurgically — typically 8 or 9/0 nylon suture under the operating microscope. Reperfusion of the hand is the critical moment: the clamps are released and the transplanted hand pinks up as blood fills it for the first time.
The flexor and extensor tendons (of the fingers, thumb, and wrist) are then repaired sequentially. The median, ulnar, and radial nerves are coaptated — the cut nerve ends are sutured with fine sutures under microscopic magnification. Skin closure is performed last, with split-thickness skin grafting used for any skin defects. The patient is transferred to ICU for post-operative monitoring of the hand's perfusion, temperature, and capillary refill.
Procedure Steps
- Multi-month pre-transplant assessment: medical, psychological, rehabilitation team clearance
- Blood group and tissue matching; waiting list registration
- Donor notification and hand procurement from a brain-dead deceased donor
- Simultaneous recipient stump preparation and donor hand procurement teams
- Bone fixation with plates and screws; arterial anastomosis; reperfusion
- Tendon repairs; nerve coaptation; skin closure
- ICU monitoring; immunosuppression commenced (tacrolimus, mycophenolate, prednisolone)
- Intensive hand therapy and rehabilitation commencing from week 1 post-op
Cost Comparison Worldwide
Country — Range — Savings
--- — --- — ---
USA — $150,000 – $300,000 — Save up to 80%
France/UK — €80,000 – €150,000 (where performed) — Save up to 75%
UAE — Not routinely performed
India — $40,000 – $80,000 — Best value
Hand transplantation in the USA — at the handful of centres that perform it — costs $150,000–$300,000 for the surgical procedure alone, not including the lifetime cost of immunosuppression ($15,000–$25,000 per year) or rehabilitation. In India, the surgical procedure costs $40,000–$80,000 at specialist centres. Immunosuppression medications in India cost significantly less than in the USA or UK — tacrolimus and mycophenolate are available as high-quality generics in India at a fraction of the branded Western price.
Recovery & Follow-up
The first 72 hours after transplant are the most critical — the hand is monitored continuously for signs of arterial or venous compromise (colour change, temperature drop, loss of capillary refill) that would require immediate surgical exploration. Pharmacological anticoagulation is maintained for the first 48–72 hours to protect the vascular anastomoses.
Motor and sensory nerve recovery follows the rate of axonal regeneration — approximately 1 mm per day. Sensation returns to the forearm within weeks; to the palm within 3–6 months; to the fingertips within 12–18 months. Motor recovery — the ability to flex and extend the fingers — follows a similar timeline. Hand therapy (passive and active mobilisation, splinting, sensory re-education, functional training) is intensive and continuous throughout.
Most patients achieve meaningful hand function by 12–18 months. The quality of the functional outcome depends on the level of amputation (more distal amputations have shorter nerve regrowth distances and better outcomes), the duration of amputation before transplant (shorter duration = better residual hand musculature), the quality of the rehabilitation programme, and patient motivation.
Recovery Tips
- Attend hand therapy sessions without fail — rehabilitation is as important as the surgery itself in determining the functional outcome
- Take immunosuppression medications at exactly the prescribed times every day — missing doses risks acute rejection
- Monitor the hand's colour, temperature, and swelling and report any sudden changes immediately
- Protect the transplanted hand from trauma, burns, and frostbite — sensation takes months to recover and injury risk is high
- Attend regular blood tests for tacrolimus levels, renal function, and full blood count as scheduled
Risks & Complications
Hand transplant carries significant risks. Acute rejection episodes occur in 70–80% of patients in the first year and are managed with pulse steroid therapy or increased baseline immunosuppression — most episodes are reversible. Chronic rejection is the major long-term threat and is the leading cause of hand transplant failure requiring amputation of the transplanted hand.
Immunosuppression risks include: opportunistic infections (CMV, PCP, fungal); nephrotoxicity (tacrolimus-induced renal dysfunction — requires careful monitoring and dose adjustment); post-transplant diabetes mellitus (steroid-induced); hypertension; hyperlipidaemia; and a small but real increased risk of certain cancers (skin cancer, lymphoma) with long-term immunosuppression. The risk-benefit calculation is different for each patient — bilateral amputees with the greatest functional deficit benefit most; unilateral amputees should carefully consider whether the risk of lifelong immunosuppression is justified against the benefit of one hand when a prosthetic can provide reasonable function.
Why GAF Healthcare
GAF Healthcare connects hand transplant candidates with India's specialist microsurgery centres that have experience in composite tissue allotransplantation and in the complex long-term management programme it requires. We coordinate the full pre-transplant assessment, waiting list registration, and post-transplant immunosuppression and rehabilitation follow-up. For international patients, we facilitate ongoing immunosuppression prescription and monitoring through our telemedicine partnership with the transplant team.
Frequently Asked Questions
How long does it take to regain hand function after transplant?
Meaningful grip and pinch function typically begins to develop at 6–12 months. Fingertip sensation returns by 12–24 months. Full functional potential — including fine motor tasks such as writing, buttoning, and tool use — is usually reached by 18–36 months with consistent hand therapy. Some patients achieve remarkably natural-looking and functioning hands; others plateau at a level of function that is useful but not complete.
Is hand transplant available for children?
Hand transplant has been performed in children in a small number of cases internationally. The considerations are particularly complex in children: the immunosuppression risks are more significant over a longer life ahead; skeletal growth means the transplanted hand may not grow proportionately; and the psychological impact is profound. Each case is assessed individually. GAF Healthcare's partner centres will provide honest, evidence-based guidance on paediatric candidacy.
What happens if the transplanted hand is rejected?
Acute rejection (the most common form) is usually reversible with treatment — increased immunosuppression stops the rejection episode and hand function is preserved. Chronic rejection is progressive and not fully reversible. If the transplanted hand undergoes severe chronic rejection or infection causing non-viability, amputation of the transplanted hand may be required. The patient then returns to their pre-transplant amputation status and can use prosthetics. The immunosuppression is discontinued after amputation.